Aside

caption



View this CV online with links at brennanbeal.com/cv/

Contact

Language Skills

R
C++
Git
SQL

Disclaimer

Made with the R package pagedown.

The source code is available on github.com/btbeal/cv.

Last updated on 2022-04-03.

Main

Brennan Beal

I am a pharmacist turned data scientist excited about bridging the gap between data and people. My favorite projects are cross-functional in nature and revolve around creating efficiencies in the way that data is understood and delivered.

Industry Experience

Quantitative Scientist

Flatiron Health

New York, NY

Current - 2021

  • Leading Syntech in the automation and deployment of a quality assessment pipeline to cut monthly engineering time by 75%
  • Collaborating with our clinicians to develop R packages for scaling the speed at which we can deliver data sets to clients
  • Conducting research on the use of real-world data (RWD) for ex-US HTA use cases, including collaboration with NICE, UK and thought leadership surrounding the transportability of US-generated real-world evidence
  • Researching clinical and socioeconomics barriers to access for Chimeric antigen receptor (CAR) T-cell therapy patients
  • Thought leader for target-trial emulation to reduce immortal time bias when conducting observational research

Post-Doctoral Healthcare Economics Research Fellow

AbbVie with the University of Washington

Seattle, WA

2021 - 2019

  • Created and began marketing an RShiny app, the Real-World Evidence Assessments and Nee¬ds Guidance (REAdi) Tool, to assist payers in streamlining the process of RWE synthesis and decision-making, which went on to receive $50,000 in funding
  • Designed and led a study indicating large US payers spend >$315M on preventable glaucoma costs supporting legacy Allergan’s second largest durable growth area prior to the acquisition
  • Managed vendors to support an economic value story for AbbVie’s $2.3B eye care portfolio

Independent Consultant/Entrepreneur

Chiesi USA, Inc.

Raleigh, NC

2019 - 2018

  • Restructured FY 2020 marketing strategy by identifying a $600k profit opportunity within their provider outreach program
  • Optimized marketing efforts for an $80M product by demonstrating the synergistic effect of two separate in-house marketing teams, yielding a 300% increase in uptake compared to no marketing


Selected Publications, Posters, and Talks

Passport for Travel: Proposed Framework for Transportability of Oncology Real World Evidence1

ISPOR 2022 Poster

N/A

2022

  • Brennan Beal, Ivy Altomare, Joshua Ray, Danielle Bargo, Blythe Adamson

Comparing Healthcare Resource Utilization and Costs for Patients with Normal Tension Glaucoma Across Levels of Severity: A Retrospective Cohort Study2

Clinical Ophthalmology

N/A

2021

  • Brennan Beal, Vanessa Shih, Joanna Campbell, David Veenstra, and Beth Devine

Online tools to synthesize real-world evidence of comparative effectiveness research to enhance formulary decision making3

Journal of Managed Care and Specialty Pharmacy

N/A

2021

  • Shuxian Chen, Jennifer Graff, Sophia Yun, Brennan Beal, Jamie T Ta, Aasthaa Bansa, Joshua J Carlson, David L Veenstra, Anirban Basu, and Beth Devine

Intro to R4

University of Washington

N/A

2021

  • Developed and led a course to teach incoming PhD and Fellows the basics of understanding data with R

REAdi Tool for RWE Evaluation

R/Medicine 2020

N/A

2020

  • Invited to present5 the REAdi Tool as a novel use case for RShiny

Package Development

adheRenceRX6

CRAN

N/A

2020

  • Authored an opinionated set of R functions, which leverage C++ to improve the speed and efficiency at which researchers can conduct pharmaceutical adherence assessment

Selected Writing

In my spare time, I really enjoy learning and teaching others - when I get curious about a subject, I’ll usually write about it7

Indifference Curves Explained Through Visualization8

Personal Blog

N/A

2019

  • Understanding the economic theory of utility is often accomanied by two-dimensional graphs of indifference curves; however, this can sometimes be confusing and misleading. This post is meant to demystify indifference curves through three-dimensional visualizations.

Expected Loss as a Way to Better Communicate Cost Effectiveness9

Personal Blog

N/A

2019

  • Discussing why the technology most likely to be cost-effective may not always be the best option for reducing risk

Education

M.S., Healthcare Economics and Outcomes Research

University of Washington

Seattle, WA

2021

  • University Graduate Fellow
  • Thesis: Comparing Healthcare Resource Utilization and Costs for Patients with Normal Tension Glaucoma Across Levels of Severity: A Retrospective Cohort Study
  • First Fellow to receive the University of Washington School of Pharmacy Graduate Student Leadership Award

Doctor of Pharmacy

University of North Carolina

Chapel Hill, NC

2019

  • Focused on healthcare economics and value of pharmacists in primary care clinics

B.S., Structural and Molecular Biochemistry

North Carolina State University

Raleigh, NC

2015